Kolon Life Science Inc. (KOSDAQ:102940)
51,300
-2,300 (-4.29%)
May 20, 2026, 3:30 PM KST
111.55% (1Y)
| Market Cap | 671.55B +88.7% |
| Revenue (ttm) | 208.98B +29.5% |
| Net Income | 24.96B |
| EPS | 1,824.00 |
| Shares Out | 13.09M |
| PE Ratio | 28.13 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 34,399 |
| Average Volume | 45,343 |
| Open | 53,500 |
| Previous Close | 53,600 |
| Day's Range | 50,200 - 53,500 |
| 52-Week Range | 23,750 - 72,700 |
| Beta | n/a |
| RSI | 35.20 |
| Earnings Date | Apr 3, 2026 |